@inbook{0a970ed206f9418caf7ec5ae5a6e8e6a,
title = "Hypoxia mediates tumor malignancy and therapy resistance",
abstract = "Hypoxia is a hallmark of the tumor microenvironment and contributes to tumor malignant phenotypes. Hypoxia-inducible factor (HIF) is a master regulator of intratumoral hypoxia and controls hypoxia-mediated pathological processes in tumors, including angiogenesis, metabolic reprogramming, epigenetic reprogramming, immune evasion, pH homeostasis, cell migration/invasion, stem cell pluripotency, and therapy resistance. In this book chapter, we reviewed the causes and types of intratumoral hypoxia, hypoxia detection methods, and the oncogenic role of HIF in tumorigenesis and chemo- and radio-therapy resistance.",
keywords = "Angiogenesis, Cell motility, Epigenetics, HIF, Hypoxia, Hypoxia imaging, Metabolism, Stem cell, Therapy resistance, Tumorigenesis",
author = "Weibo Luo and Yingfei Wang",
note = "Funding Information: Work in authors{\textquoteright} laboratories was supported by grants from NIH (R00CA168746), CPRIT (RR140036), Susan G. Komen{\textregistered} (CCR16376227), Welch Foundation (I-1903-20160319), and American Cancer Society and UTSW Simmons Cancer Center (ACS-IRG-02-196) to W.L.; and NIH (R00NS078049, R35GM124693), Welch Foundation (I-1939-20170325), CPRIT (RP170671), Darrell K Royal Research Fund, TIBIR pilot grant, and UTSW startup funds to Y.W.. W.L. is a CPRIT Scholar in Cancer Research. Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2019.",
year = "2019",
doi = "10.1007/978-3-030-12734-3_1",
language = "English (US)",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "1--18",
booktitle = "Advances in Experimental Medicine and Biology",
}